The synergistic effect of the combination of anti‐PD1 and Lenti‐HPV‐07 is also consistent with the reported improvement in tumor eradication potential of LV‐based melanoma immunotherapy by PD1/PDL1 blockade (Albershardt et al, 2020). This evidence concerns the gene CD274 and melanoma.